Hospitals in European Union 2026: Industry Statistics & Trends

The hospitals industry in the European Union provides vital inpatient, outpatient, and specialized medical care through a combination of public, non-profit, and private operators. The sector is moving toward structural modernization, with a clear trend toward shifting minor procedures to outpatient or day-care settings to increase efficiency. This structural shift is reflected in Eurostat data, which shows a continuous optimization of infrastructure as current healthcare expenditure in the EU reached €1,720 billion in 2023 (Eurostat), representing approximately 10.0% of the Union's gross domestic product.

Industry snapshot

Key public data points

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Hospitals in European Union industry cover?

The industry encompasses the activities of general and specialized short-term or long-term hospitals, medical nursing institutions, and rehabilitation centers that provide inpatient medical, surgical, and psychiatric care. It primarily focuses on facilities that house overnight or extended-stay diagnostic and treatment services managed by licensed medical practitioners. Day-care clinics and independent outpatient treatment facilities are tightly integrated into this ecosystem but distinct from traditional inpatient activities.

• •Classified under NACE Division 86 (Human Health Activities) and specifically NACE Code 86.10 for Hospital Activities.
• •Includes specialized centers such as substance abuse hospitals, sanatoria, and psychiatric institutions.
• •Excludes purely outpatient medical practices and dental offices, which are categorized separately under NACE 86.2.

Who operates in the industry and how is it structured?

The market structure varies considerably by member state, generally utilizing a universal coverage architecture funded through social health insurance systems or national taxation. Infrastructure relies on heavily subsidized public entities alongside a growing presence of commercial and non-profit independent providers. Operational focus has intentionally pivot away from maintaining high permanent bed capacities toward increasing the velocity of patient throughput.

• •The EU average hospital bed availability dropped slightly to 507 beds per 100,000 people in 2024, down from 511 in 2023.
• •Bulgaria maintained the highest domestic ratio with 870 beds per 100,000 people in 2024, followed closely by Germany at 759 beds.
• •Sweden and the Netherlands recorded some of the leanest configurations, reporting 187 and 221 beds per 100,000 people respectively in 2024.

What drives demand in the industry?

The primary catalyst for industry utilization is the rapidly aging demographic profile across the European Union, which correlates with an increasing burden of chronic illness and multi-morbidity. Rising macroeconomic investments in health infrastructure by member governments to match public expectations also push volume and service capabilities upward. Additionally, the adoption of complex clinical technologies requires heavy, centralized capital allocations that favor concentrated hospital environments.

• •Current healthcare expenditure across the European Union reached an aggregate of €1,720 billion in 2023.
• •Germany and France led relative health spending allocations in 2023, consuming 11.7% and 11.5% of their respective national GDPs.
• •Between 2014 and 2023, per-inhabitant healthcare expenditure more than doubled in Eastern EU nations including Romania, Bulgaria, and Lithuania.

Who are the notable companies in the industry?

While public, state-owned entities handle the majority of acute-care volumes across Europe, commercial operators have successfully built extensive transnational hospital networks. These private actors compete for corporate contracts, elective procedures, and state-reimbursed patient allocations by standardizing care paths and scaling administrative purchasing power. The market features highly consolidated multinational networks alongside fragmented municipal facilities.

• •Fresenius SE & Co. KGaA operates Helios, Europe's largest private healthcare provider, which generated over €12 billion in total sales in 2023.
• •Ramsay Santé, listed publicly in France, serves as a primary provider across 5 European countries with over 350 facilities following its historic acquisition of Capio AB.
• •Quirónsalud operates as a dominant commercial hospital brand within Spain, managing 57 hospitals and generating €4.8 billion in revenue during 2023 under the Helios Health corporate umbrella.
• •Orpea SA (now operating under the brand emea/LNA Sante ecosystems in related acute care segments) and Korian (now Clariane SE) interact closely with hospital systems regarding post-acute and rehabilitation beds.

What are the recent trends and outlook?

The industry is adapting to acute workforce challenges and shifting patient management guidelines that heavily emphasize ambulatory medicine. Surgical interventions are becoming less invasive, enabling hospitals to transition traditional multi-day inpatient treatments into same-day out-patient procedures. This evolution directly helps mitigate structural nurse and physician shortages by condensing overnight staff demands.

• •Scientific advancements have successfully shortened the average length of stay for primary in-patient procedures across the region.
• •The continuous downward trajectory of total active hospital beds from 582 per 100,000 in 2009 to 507 in 2024 mirrors this day-care substitution.
• •More than 5 million localized cataract procedures were processed inside the EU in 2023, heavily leaning on efficient outpatient workflows.

How is the industry regulated?

European hospital networks are highly constrained by strict national and regional legal frameworks governing clinical quality, fiscal reimbursement, and patient rights. Operational data integrity, workforce working-hour mandates, and medical device standards are dictated at the EU level to guarantee cross-border interoperability. National health authorities control regional hospital planning, determining precisely where facilities can expand or modify service lines.

• •Data collection, structural visibility, and business activity profiling conform rigidly to Regulation (EC) No 1893/2006.
• •Reimbursement systems are strictly tethered to national implementations of the Diagnosis-Related Groups (DRG) pricing matrix.
• •Quality standards and reporting metrics are aligned with updated Eurostat and European Statistical System (ESS) data paradigms formalized for 2025/2026 deployment.

Government, statistical and trade sources used for this Claight analysis.

• Eurostat Healthcare Expenditure Statistics 2023 Overview ·
• Eurostat Healthcare Resources (Beds) Dataset 2024/2026 ·
• European Commission NACE Rev. 2.1 Statistical Classification Manual 2024 ·
• Fresenius SE & Co. KGaA Annual Corporate Disclosures 2023 ·
• Ramsay Santé Investor Relations and Corporate History Reports